AR111715A1 - ANTICUERPOS ANTI-SIRPa - Google Patents
ANTICUERPOS ANTI-SIRPaInfo
- Publication number
- AR111715A1 AR111715A1 ARP180100931A ARP180100931A AR111715A1 AR 111715 A1 AR111715 A1 AR 111715A1 AR P180100931 A ARP180100931 A AR P180100931A AR P180100931 A ARP180100931 A AR P180100931A AR 111715 A1 AR111715 A1 AR 111715A1
- Authority
- AR
- Argentina
- Prior art keywords
- sirpa antibodies
- antibodies
- sirpa
- diseases
- cancer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2887—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A61K2039/507—Comprising a combination of two or more separate antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Abstract
La presente solicitud se relaciona con anticuerpos anti-SIRPa, así como al uso de estos anticuerpos en el tratamiento de enfermedades tales como el cáncer y enfermedades infecciosas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL2018708A NL2018708B1 (en) | 2017-04-13 | 2017-04-13 | ANTI-SIRPα ANTIBODIES |
Publications (1)
Publication Number | Publication Date |
---|---|
AR111715A1 true AR111715A1 (es) | 2019-08-14 |
Family
ID=60020552
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP180100931A AR111715A1 (es) | 2017-04-13 | 2018-04-13 | ANTICUERPOS ANTI-SIRPa |
Country Status (2)
Country | Link |
---|---|
AR (1) | AR111715A1 (es) |
NL (1) | NL2018708B1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113735973B (zh) * | 2020-05-28 | 2023-05-09 | 中国科学院微生物研究所 | 一种抗SIRPα抗体及其应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1048299A1 (en) * | 1999-04-28 | 2000-11-02 | Faculteit der Geneeskunde van de Vrije Universiteit | Method for inhibiting cell functioning for use in anti-inflammatory and anti-tumour therapies |
WO2013056352A1 (en) * | 2011-10-19 | 2013-04-25 | University Health Network | Antibodies and antibody fragments targeting sirp-alpha and their use in treating hematologic cancers |
SG11201607143UA (en) * | 2014-03-11 | 2016-09-29 | Univ Leland Stanford Junior | Anti sirp-alpha antibodies and bi-specific macrophage enhancing antibodies |
-
2017
- 2017-04-13 NL NL2018708A patent/NL2018708B1/en active
-
2018
- 2018-04-13 AR ARP180100931A patent/AR111715A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
NL2018708B1 (en) | 2018-10-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NI201700019A (es) | Anticuerpos anti tigit | |
CL2021000088A1 (es) | Anticuerpos anti-cd27 (divisional de solicitud 779-2019). | |
MX2019012233A (es) | Anticuerpos anti-sirpa. | |
MD3370770T2 (ro) | Formulări subcutanate de anticorpi anti-CD38 și utilizări ale acestora | |
PH12015501071A1 (en) | Combination therapy of anti-her3 antibodies | |
BR112018010279A2 (pt) | novos anticorpos anti-emr2 e métodos de uso | |
CO2020016131A2 (es) | Agonistas de tlr7 | |
BR112018012884A2 (pt) | novos anticorpos anti-mmp16 e métodos de uso | |
MX2020000636A (es) | Proteinas sinteticas y usos terapeuticos de las mismas. | |
AR111715A1 (es) | ANTICUERPOS ANTI-SIRPa | |
AR120118A2 (es) | Anticuerpos anti tigit | |
EA202091619A3 (ru) | Антитела против tigit | |
CO7131362A2 (es) | Terapia de combinación de anticuerpos anti-mif y glucocorticoides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |